This study is currently not recruiting participants.

Concordance of sensitivity and resistance testing between Cisplatin and Ifosfamide in Soft Tissue Sarcomas: A Retrospective Review

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

This study is as a retrospective database including clinical information from patients with soft tissue sarcomas seen at IUSCC during the period June 2010 ? June 2012 and treated with the specific chemotherapy agents, Cisplatin and Ifosfamide. Researchers propose to perform a retrospective record review of adult patients who had cisplatin and Ifosfamide sensitivity and resistance testing by Precision Therapeutics laboratory (Pittsburgh, PA). Researchers will determine whether there are perhaps 2 or 3 histologic subtypes of soft tissue sarcoma that are more likely to be sensitive or resistant to cisplatin. Researchers will record whether the patients ever received cisplatin or ifosfamide from June 2010 through June 2012 for the treatment of soft tissue sarcoma. Toxicity and response will be assessed in patients who were tested for cisplatin or ifosfamide sensitivity. Researchers will also determine if there was correlation of clinical response with laboratory live tissue testing.

Description

This study is as a retrospective database including clinical information from patients with soft tissue sarcomas seen at IUSCC during the period June 2010 ? June 2012 and treated with the specific chemotherapy agents, Cisplatin and Ifosfamide. Researchers propose to perform a retrospective record review of adult patients who had cisplatin and Ifosfamide sensitivity and resistance testing by Precision Therapeutics laboratory (Pittsburgh, PA). Researchers will determine whether there are perhaps 2 or 3 histologic subtypes of soft tissue sarcoma that are more likely to be sensitive or resistant to cisplatin. Researchers will record whether the patients ever received cisplatin or ifosfamide from June 2010 through June 2012 for the treatment of soft tissue sarcoma. Toxicity and response will be assessed in patients who were tested for cisplatin or ifosfamide sensitivity. Researchers will also determine if there was correlation of clinical response with laboratory live tissue testing.

Details
Condition soft tissue sarcoma
Age 100years or below
Clinical Study IdentifierTX7261
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.